Antimicrobial peptides : triumphs and challenges
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Future medicinal chemistry - 13(2021), 16 vom: 01. Aug., Seite 1313-1315 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zeng, Zi-Zhen [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 26.01.2022 Date Revised 26.01.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.4155/fmc-2021-0134 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM326958290 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM326958290 | ||
| 003 | DE-627 | ||
| 005 | 20231225195720.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4155/fmc-2021-0134 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1089.xml |
| 035 | |a (DE-627)NLM326958290 | ||
| 035 | |a (NLM)34148371 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zeng, Zi-Zhen |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Antimicrobial peptides |b triumphs and challenges |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.01.2022 | ||
| 500 | |a Date Revised 26.01.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a PEGylation | |
| 650 | 4 | |a antimicrobial peptides | |
| 650 | 4 | |a clinical translation | |
| 650 | 4 | |a hemolysis | |
| 650 | 4 | |a peptidomimetic | |
| 650 | 4 | |a prodrug | |
| 650 | 4 | |a proteolytic instability | |
| 650 | 4 | |a secondary structure | |
| 650 | 4 | |a structure–activity relationship | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 650 | 7 | |a Antimicrobial Peptides |2 NLM | |
| 700 | 1 | |a Huang, Shu-Hui |e verfasserin |4 aut | |
| 700 | 1 | |a Alezra, Valérie |e verfasserin |4 aut | |
| 700 | 1 | |a Wan, Yang |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Future medicinal chemistry |d 2009 |g 13(2021), 16 vom: 01. Aug., Seite 1313-1315 |w (DE-627)NLM194822109 |x 1756-8927 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2021 |g number:16 |g day:01 |g month:08 |g pages:1313-1315 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4155/fmc-2021-0134 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2021 |e 16 |b 01 |c 08 |h 1313-1315 | ||